Navigation Links
GenomeDx Expands Collaboration with Mayo Clinic
Date:4/29/2013

SAN DIEGO, April 29, 2013 /PRNewswire/ -- GenomeDx Biosciences announced today that it has expanded an existing research agreement with the Mayo Clinic. The expanded agreement includes exclusive license to certain Mayo developed intellectual property along with exclusivity covering co-developed intellectual property.   The agreement also includes continued access to the clinical data concerning Mayo Clinic's cohort of prostate cancer samples to allow for longer-term follow up and evaluation of biomarkers. The initial collaboration entered in 2009 led to the development of Decipher™, a transformative genomic test that forecasts risk of metastasis in men with prostate cancer. In addition, GenomeDx announced that five studies evaluating the ability of Decipher to predict metastatic prostate cancer will be featured at the 2013 American Urological Association (AUA) Annual Meeting.

"Access to the Mayo Clinic's comprehensive cohort of samples from patients classified as high risk for metastatic disease and the involvement of Mayo Clinic researchers has been essential to the development of Decipher," said Doug Dolginow , M.D., Chief Executive Officer of GenomeDx. "With Mayo Clinic's large collection of patient samples that had developed metastatic disease, we could reliably identify and validate gene sequences associated with lethal prostate cancer and to create the Decipher test."

Abstracts Related to Decipher at AUA 2013

Podium presentation (May 8, 2013, 8:00-10:00 a.m. Pacific Time)

  • Validation of a genomic classifier that predicts metastatic disease progression in men with high risk pathological features post-prostatectomy, presented by R. Jeffrey Karnes , M.D., associate professor and Vice-Chair in Urology at Mayo Clinic
  • Location: San Diego Convention
    '/>"/>

SOURCE GenomeDx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Millstone Medical Outsourcing Expands Medical Device Distribution Services
2. Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients Increased Asia Pacific Focus
3. Zosano Pharma, Inc. Expands Board of Directors with Addition of Kleanthis G. Xanthopoulos, Ph.D.
4. Relievant Medsystems Achieves Completion of Interim Safety Data Analysis of Intracept in SMART Pivotal Study and Expands Senior Leadership Team
5. Western Maryland Health System Expands Use of Versus RTLS to Enhance Staff Safety
6. Compass Diversified Holdings Expands Term Loan Facility by $30 Million and Lowers Interest Rate by 1.25%
7. Phonak Expands Its Quest Platform with New Product Lines
8. Everyday Health Expands Solutions For Pharmaceutical Industry Marketers
9. BioElectronics Expands European Distribution to Malta
10. SAFC Expands PharmaGrade Raw Materials Portfolio to Meet Growing Demand; Expects to Double PharmaGrade Portfolio in 2013
11. Accelovance Expands Oncology Leadership with the Addition of Ralph Boccia, MD as Oncology Medical Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2015)... CAMBRIDGE, Mass. , April 19, 2015 /PRNewswire/ ... that its drug candidate BLU-285 has significant anti-tumor ... (GIST) and achieved and maintained complete tumor regression ... level. These data were presented at the American ... "Despite advances in treating GIST, there ...
(Date:4/17/2015)... - The issue: In consultation ... lot (lot 710535) of Clavulin-400 (70mL) after receiving a complaint ... in one bottle of the  product. No other lots of ... Clavulin-400 is an oral antibiotic used in adults and children ... Clavulin-400 comes as a powder in bottles and is mixed ...
(Date:4/17/2015)... RALEIGH, N.C. , April 17, 2015 /PRNewswire/ ... of the Integrated Embolic Protection™ filter platform for ... completion of a $5.6 million Series B financing ... stage venture firm with a focus on medical ... medicine. The round also included Mountain Group Partners, ...
Breaking Medicine Technology:Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity of BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets 2Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity of BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets 3Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity of BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets 4Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 2Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 3
...  Russia,s first Leksell Gamma Knife® Perfexion™ system has found ... just a five-minute car ride from Moscow,s Red Square. ... first Perfexion patient, receiving Gamma Knife® radiosurgery to treat ... months later, the Institute has treated more than 400 ...
... ENMD ), a clinical-stage pharmaceutical company developing therapeutics ... Ph.D has joined the Board of Directors as Executive Chairman ... of the Board of Directors. (Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO ... CEO and Chairman of OriGene Technologies, Inc. He also is ...
Cached Medicine Technology:Largest Neurosurgical Center in Russia Acquires Elekta's Leksell Gamma Knife Perfexion 2Largest Neurosurgical Center in Russia Acquires Elekta's Leksell Gamma Knife Perfexion 3Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors 2Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors 3Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors 4
(Date:4/19/2015)... April 20, 2015 The urinalysis ... and sediment urinalysis. The biochemical urinalysis market is ... players and several small players. Prominent players in ... Roche Diagnostics (Switzerland) and Danaher Corporation (U.S.) while ... include Danaher Corporation (U.S.), Sysmex Corporation (Japan) and ...
(Date:4/19/2015)... Lapeer, Michigan (PRWEB) April 19, 2015 ... located at 809 W. Dryden Road, Metamora, MI. 48455. ... greater Lapeer area. , Days and hours are Thursdays ... number is 248-731-5442. , Women’s Excellence is the most ... specialize in menopause, weight control, bladder control, endometriosis, robotic ...
(Date:4/19/2015)... April 19, 2015 Women’s Excellence ... now Metamora (Michigan), now offers pelvic organ prolapse treatment. ... muscles, connecting tissue (fascia), and thickened pieces of fascia ... weakened, the fascia and ligaments have to bear the ... fail, allowing pelvic organs to drop and press into ...
(Date:4/19/2015)... 19, 2015 Carinsuranceshoppingsource.com has released a ... under a cheap auto insurance plan . ... models can be covered under cheap auto insurance plans. ... motorcycle models. These models are also cheaper to insure. ... have a big influence on the auto insurance plan ...
(Date:4/19/2015)... (PRWEB) April 19, 2015 Autocarinsurancecheap.com has ... insurance can offer financial protection for vulnerable family ... benefits if the insured dies or is disabled in ... it is commonly bought with an auto insurance plan. ... that is similar to a life insurance policy. The ...
Breaking Medicine News(10 mins):Health News:The Urinalysis Systems Market to Reach $1.28 Billion by 2019 - MarketsandMarkets 2Health News:The Urinalysis Systems Market to Reach $1.28 Billion by 2019 - MarketsandMarkets 3Health News:Women's Excellence Now Offers Pelvic Organ Prolapse Treatment 2Health News:Buying Auto Insurance for Motorcycles - Models That Are Cheap to Cover! 2Health News:Accidental Death and Dismemberment Insurance Can Provide Financial Security! 2
... April 10 ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin ... at,prestigious institutes in France and Italy will ... anticancer compound, ProLindac(TM), at the,American Association for ... April 12-16, 2008 at the San Diego ...
... Grant Made as Part of Foundation,s $1 Million Make ... Reader,s Digest,Foundation (RDF) announced today that it will donate ... end-of-life,care for all and bereavement programs for family members, ... April, is the,second in a series of ten $100,000 ...
... U.S. Senate, Several Governors and Mayors Support Event, ... 2008,the inaugural National Healthcare Decisions Day (NHDD), will ... public and professionals about,advance healthcare planning., "With ... know,your wishes to honor them," said Nathan A. ...
... Two University of Kentucky researchers from the department ... and Information Studies have learned that targeted mass ... high sensation-seeking, impulsive decision-making young adults to adopt ... health campaigns, particularly those promoting healthy behaviors, were ...
... Diagnosis and treatment of,rheumatoid arthritis in the ... a patient,s well-being. Yet primary care providers, ob/gyns,and ... these patients and,in developing a coordinated approach to ... of health care providers, The Journal of Family,Practice ...
... commitment to schools by allocating ... additional funds for ... through the Highmark Healthy High 5 School Challenge, recently,awarded ... schools across,Pennsylvania. The grants will support programs that address ...
Cached Medicine News:Health News:Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference 2Health News:Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference 3Health News:The Reader's Digest Foundation to Donate $100,000 to National Hospice Foundation 2Health News:The Reader's Digest Foundation to Donate $100,000 to National Hospice Foundation 3Health News:National Healthcare Decisions Day in All 50 States, DC, Puerto Rico, and Internationally 2Health News:Researchers find mass media campaigns useful 2Health News:Publications Seek to Improve Outcomes for Patients With Rheumatoid Arthritis 2Health News:Highmark Healthy High 5 School Challenge Program Awards $605,000 in Grants to 75 Pennsylvania Schools 2Health News:Highmark Healthy High 5 School Challenge Program Awards $605,000 in Grants to 75 Pennsylvania Schools 3Health News:Highmark Healthy High 5 School Challenge Program Awards $605,000 in Grants to 75 Pennsylvania Schools 4Health News:Highmark Healthy High 5 School Challenge Program Awards $605,000 in Grants to 75 Pennsylvania Schools 5Health News:Highmark Healthy High 5 School Challenge Program Awards $605,000 in Grants to 75 Pennsylvania Schools 6
... 96 temperature cyclers, the gradient block can be ... up to 14 or 22 across the 40- ... of up to 2C between adjacent wells in ... to 12 different annealing temperatures in a single ...
... has a graphical touch screen display which ... the "touch of a screen." Features ... Touch Screen, Graphical Display, Memory Cards, Gradient ... Format, Intuitive Programmin, Free Instrument Software Upgrade. ...
... The Techne TC412 is a high performance, ... price. Features & Benefits include: Flexible ... intuituve programming, 8 peltiers, PC networking. Includes ... Up to 32 Techne cyclers can be connected ...
... 32 Thermal Block has a compact design for personal ... rapidly, and can handle up to 32 samples simultaneously. ... there is no need to add mineral oil to ... programs can be stored, and up to 15 steps ...
Medicine Products: